期刊文献+

沙利度胺对晚期NSCLC维持治疗中安全性及血清中bFGF水平的影响

在线阅读 下载PDF
导出
摘要 目的探讨沙利度胺对晚期非小细胞肺癌(NSCLC)维持治疗中疗效及安全性,并应用酶联免疫吸附测定法(enzyme-linked immunosorbent assay,ELISA)检测NSCLC患者维持治疗前、后血清中碱性成纤维细胞生长因子(basic fibroblast growth factor,bFGF)水平变化及其相关性。方法 60例NSCLC患者,随机分治疗组和对照组。2~3月复查,评价疗效及安全性,分析其治疗前后两组血清中bFGF浓度变化与肿瘤增长及消退的相关性。结果两组RR差异无统计学意义(P>0.05),但治疗组DCR高于对照组,差异有统计学意义(P﹤0.05);1年后两组患者血清中bFGF的浓度均较治疗前降低,但治疗组较对照组下降明显(P<0.05)。治疗组不良反应较对照组重,主要为嗜睡、头晕等,但大多患者逐渐耐受。结论沙利度胺维持治疗能够提高晚期NSCLC患者维持治疗中的DCR,且毒副反应可以耐受,安全性好;可降低NSCLC患者血清bFGF的表达水平。
出处 《泰山医学院学报》 CAS 2018年第2期209-210,共2页 Journal of Taishan Medical College
  • 相关文献

参考文献5

二级参考文献54

  • 1Kessler T, Fehrmann F, Bieker R, et al. Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies [J]. Curr Drug Targets, 2007,8 (2) : 257-268.
  • 2Hulin C, Faeon T, Rodon P, et al. Efficacy of melphalan and prednisone puls thalidomide in patients older than 75 years with newly diagnosed multiple myeloma [J]. Clin Oncol, 2009, 27(22) :3664-3670.
  • 3Padro T, Ruiz S, Bieker R, et al. Increase angiogenesis in the bone marrow of patients with acute myeloid leukemia [J]. Blood, 2000,95 ( 8 ) : 2637-2644.
  • 4Hicklin D J, Ellis L M. Role of the vascular endothelial growth factor pathway intumor growth and angiogenesis [J]. Clin Oncol, 2005,23 ( 5 ) : 1011-1027.
  • 5Eichholz A, Merchant S, Gaya A M. Anti-angiogenesis therapies : their potential in cancer management [J]. Onco Target Ther, 2010,24(3) :69-82.
  • 6Keyhani A, Jendiroba D R, Freireich E J. Angiogenesis and leukemia [J]. Leuk Res, 2001,25(8) :639-645.
  • 7Kim D H, Lee N Y, Lee M H, et al. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukemia patients [J]. Br J Haematot, 2008,140( 1 ) : 71-79.
  • 8Nakamura T,Matsumoto K,Kiritoshi A.Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells:in vitro analysis of tumor-stromal interactions[J].Cancer Res,1997,57(15):3305-3313
  • 9Savagner P,Valles AM,Jouanneau J,et al.Alternative splicing in fibroblast growth factor receptor2is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells[J].Mol Biol Cell,1994,5(8):851-862
  • 10Restrepo-Angulo I,Sanchez-Torres C,Camacho J.Human EAG1 potassium channels in the epithelial-to-mesenchymal transition in lung cancer cells[J].Anticancer Res,2011,31(4):1265-1270

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部